Malladi N, Johny E, Uppulapu S, Tiwari V, Alam M, Adela R
J Diabetes Res. 2022; 2021:6404438.
PMID: 35127948
PMC: 8808240.
DOI: 10.1155/2021/6404438.
Madson Jr E, Chester E
Doc Ophthalmol. 2016; 37(2):217-43.
PMID: 27169910
DOI: 10.1007/BF00147260.
Yamashiro K, Tsujikawa A, Ishida S, Usui T, Kaji Y, Honda Y
Am J Pathol. 2003; 163(1):253-9.
PMID: 12819029
PMC: 1868165.
DOI: 10.1016/S0002-9440(10)63648-6.
Bridges C, Ola M, Prasad P, Ganapathy V, Smith S
Am J Physiol Cell Physiol. 2001; 281(6):C1825-36.
PMID: 11698241
PMC: 4637984.
DOI: 10.1152/ajpcell.2001.281.6.C1825.
Limb G, Webster L, Soomro H, Janikoun S, Shilling J
Clin Exp Immunol. 1999; 118(2):213-8.
PMID: 10540181
PMC: 1905412.
DOI: 10.1046/j.1365-2249.1999.01067.x.
Platelet shape change abnormalities in diabetic retinopathy.
Porta M, Hilgard P, Kohner E
Diabetologia. 1980; 18(3):217-21.
PMID: 7372026
DOI: 10.1007/BF00251919.
Effect of aspirin on platelet aggregation in diabetes mellitus.
KHOSLA P, Seth V, Tiwari H, Saraya A
Diabetologia. 1982; 23(2):104-7.
PMID: 7128964
DOI: 10.1007/BF01271169.
Studies of retinopathy and the plasma co-factor of platelet hyperaggregation in type 1 (insulin-dependent) diabetic children.
Levin R, Kwaan H, DOBBIE J, Fetkenhour C, TRAISMAN H, Kramer C
Diabetologia. 1982; 22(6):445-9.
PMID: 7049802
DOI: 10.1007/BF00282588.
Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.
Jackson J, BRESSLER R
Drugs. 1981; 22(4):295-320.
PMID: 7030708
DOI: 10.2165/00003495-198122040-00003.
The effects of clofibrate on plasma glucose, lipoproteins, fibrinogen, and other biochemical and haematological variables in patients with mature onset diabetes mellitus.
Calvert G, Blight L, Franklin J, Oliver J, Wise P, Gallus A
Eur J Clin Pharmacol. 1980; 17(5):355-62.
PMID: 6998709
DOI: 10.1007/BF00558448.
Effect of insulin treatment on prostacyclin in experimental diabetes.
HARRISON H, Reece A, Johnson M
Diabetologia. 1980; 18(1):65-8.
PMID: 6988267
DOI: 10.1007/BF01228305.
Availability of endothelial von Willebrand factor and platelet function in diabetic patients infused with a vasopressin analogue.
Porta M
Diabetologia. 1982; 23(5):452-5.
PMID: 6816652
DOI: 10.1007/BF00260961.
Hypoglycemic therapy and hemostasis in maturity- onset diabetes mellitus: existence of an early prethrombotic state.
Grignani G, Gamba G, Biancardi M, De Marco R, Grassi M, Ferrari E
Acta Diabetol Lat. 1982; 19(1):29-35.
PMID: 6803480
DOI: 10.1007/BF02581183.
Potential therapeutic applications of aspirin and other cyclo-oxygenase inhibitors.
FARAH A, Rosenberg F
Br J Clin Pharmacol. 1980; 10 Suppl 2:261S-278S.
PMID: 6776977
PMC: 1430184.
DOI: 10.1111/j.1365-2125.1980.tb01809.x.
Raised plasma fibronectin concentration is related to the presence of diabetic retinopathy.
De Giorgio L, Seghieri G, Gironi A, MAMMINI P, Bartoli U, Bartolomei G
Acta Diabetol Lat. 1984; 21(3):251-6.
PMID: 6393674
DOI: 10.1007/BF02642898.
Epoprostenol (prostacyclin, PGI2) binding and activation of adenylate cyclase in platelets of diabetic and control subjects.
Shepherd G, Lewis P, Blair I, de Mey C, MacDermot J
Br J Clin Pharmacol. 1983; 15(1):77-81.
PMID: 6342639
PMC: 1427836.
DOI: 10.1111/j.1365-2125.1983.tb01467.x.
A study of platelet-relevant parameters in patients with diabetic microangiopathy.
Porta M, Peters A, Cousins S, Cagliero E, Fitzpatrick M, Kohner E
Diabetologia. 1983; 25(1):21-5.
PMID: 6224713
DOI: 10.1007/BF00251891.
[Diabetic angiopathy and blood viscosity (author's transl)].
Muller R
Acta Diabetol Lat. 1973; 10(6):1311-24.
PMID: 4793677
DOI: 10.1007/BF02590717.
Basic considerations on treatment of increased platelet aggregation in diabetic vasculopathic patients.
Bizzi B, Leone G, Boni P
Acta Diabetol Lat. 1974; 11(6):437-45.
PMID: 4469856
DOI: 10.1007/BF02624583.
Erythrocyte aggregation in relation to diabetic retinopathy.
van Haeringen N, Oosterhuis J, TERPSTRA J, GLASIUS E
Diabetologia. 1973; 9(1):20-4.
PMID: 4121794
DOI: 10.1007/BF01225995.
